Analysis of Key Points in the Construction of Cell Culture Media Quality Control Systems and Compliance Management

Impact of Culture Medium Quality on End Products

As a critical raw material for biologics, cell therapy, and in vitro diagnostic products, cell culture medium quality directly affects process reproducibility and end-product safety. Due to the complex composition and diverse sources of culture media, finished-product testing alone cannot fully identify potential risks. A full lifecycle quality control system covering suppliers, production, testing, storage, and use must be established.

Raw Materials and Production Process Control

Raw material screening is the starting point of quality control. For components such as amino acids, vitamins, inorganic salts, buffers, and growth factors, the source, purity, and critical impurity limits should generally be specified. The production environment should be configured with the appropriate cleanliness level according to the intended use of the product. Water for injection or high-purity water is typically used, with monitoring of parameters such as microorganisms, endotoxins, and conductivity. Mixing, aliquoting, and sterilization processes should be validated for uniformity and sterility assurance level.

Supplier Audits and Qualification Document Management

Incoming raw material inspection and retention samples of critical lot numbers

Dynamic monitoring of airborne particles and microorganisms in the production environment

Equipment cleaning validation and cross-contamination prevention

Finished Product Testing Items and Performance Evaluation

Common finished product testing items include appearance, pH, osmolality, sterility test, mycoplasma test, endotoxin content, and cell growth promotion test. The growth promotion test typically uses representative cell lines cultured under specified conditions, observing parameters such as adherence, morphology, doubling time, or viability. The relevant results are used for batch release and trend analysis, providing data support for continuous improvement.

Document Traceability and Change Management

Comprehensive batch production records, testing records, and supplier change records are the foundation of traceability in a quality system. Any change involving formulation, critical raw material suppliers, or production processes should undergo risk assessment, with comparability studies conducted when necessary. Through trend analysis and periodic quality reviews, potential deviations can be identified early, reducing the impact of supply chain fluctuations.

Regulatory and Standards Trends

The Chinese Pharmacopoeia, Good Manufacturing Practice for Drugs, and internationally accepted guidelines set forth principle-based requirements for quality control and supplier management of cell culture media. When establishing in-house specifications, companies may refer to general pharmacopoeial requirements and develop specific limits based on product characteristics. As the regulatory system for cell and gene therapy products gradually improves, attention to residual medium components, animal-derived risks, and viral clearance validation will continue to increase.